We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$1.85B
AUM Growth
+$108M
Cap. Flow
+$1.57M
Cap. Flow %
0.08%
Top 10 Hldgs %
63.69%
Holding
284
New
10
Increased
183
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$12.2M
2
OKE icon
Oneok
OKE
+$7.4M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.38M
4
MSFT icon
Microsoft
MSFT
+$5.71M
5
KKR icon
KKR & Co
KKR
+$4.81M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$37.8M
2
OKS
Oneok Partners LP
OKS
+$7.71M
3
ETP
Energy Transfer Partners L.p.
ETP
+$4.61M
4
CVX icon
Chevron
CVX
+$3.82M
5
COP icon
ConocoPhillips
COP
+$1.84M

Sector Composition

Rank Sector Weight
1 Healthcare 54.65%
2 Energy 11.02%
3 Utilities 5.59%
4 Industrials 4.78%
5 Communication Services 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLXS icon
251
Plexus
PLXS
$6.47B
$13K ﹤0.01%
240
– –
EFA icon
252
iShares MSCI EAFE ETF
EFA
$78.5B
$12K ﹤0.01%
191
+3
+2% +$194
DELL icon
253
Dell
DELL
$262B
$11K ﹤0.01%
656
– –
TEF
254
DELISTED
Telefonica
TEF
$11K ﹤0.01%
1,359
+11
+0.8% +$98
WMB icon
255
Williams Companies
WMB
$86.7B
$11K ﹤0.01%
353
+4
+1% +$119
HP icon
256
Helmerich & Payne
HP
$3.37B
$9K ﹤0.01%
169
+2
+1% +$117
CC icon
257
Chemours
CC
$2.57B
$8K ﹤0.01%
+200
New +$7.89K
CNDT icon
258
Conduent
CNDT
$245M
$8K ﹤0.01%
530
– –
AMLP icon
259
Alerian MLP ETF
AMLP
$12.9B
$6K ﹤0.01%
100
– –
EWJ icon
260
iShares MSCI Japan ETF
EWJ
$22.1B
$6K ﹤0.01%
116
+1
+0.9% +$53
ZBH icon
261
Zimmer Biomet
ZBH
$18.4B
$6K ﹤0.01%
50
– –
UAN icon
262
CVR Partners
UAN
$1.35B
$5K ﹤0.01%
151
– –
MLCO icon
263
Melco Resorts & Entertainment
MLCO
$2.24B
$4K ﹤0.01%
+200
New +$4.36K
HPQ icon
264
HP
HPQ
$24.6B
$3K ﹤0.01%
149
+1
+0.7% +$18
HPE icon
265
Hewlett Packard
HPE
$62.4B
$2K ﹤0.01%
186
-60
-24% -$835
SLNOW
266
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
$2K ﹤0.01%
+2,197
New +$2.01K
DHC
267
Diversified Healthcare Trust
DHC
$2.17B
$1K ﹤0.01%
26
– –
DXC icon
268
DXC Technology
DXC
$1.82B
$1K ﹤0.01%
+14
New +$929
FCX icon
269
Freeport-McMoran
FCX
$91.2B
$1K ﹤0.01%
44
– –
NNN icon
270
NNN REIT
NNN
$9.16B
$1K ﹤0.01%
36
-402
-92% -$16.2K
CRC
271
DELISTED
California Resources Corporation
CRC
$1K ﹤0.01%
123
– –
AMAT icon
272
Applied Materials
AMAT
$398B
– –
-725
Closed -$28K
F icon
273
Ford
F
$59.3B
– –
-425
Closed -$5K
NKE icon
274
Nike
NKE
$62.7B
– –
-300
Closed -$17K
RYAM icon
275
Rayonier Advanced Materials
RYAM
$604M
$0 ﹤0.01%
1
– –
8 9 10
11
12

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q2 2017 Portfolio in Review

As of Q2 2017, Bollard Group held 284 positions worth $1.85B, up 6.2% from $1.74B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Bollard Group's Q2 2017 filing shows 10 new, 183 increased, 15 reduced and 11 closed positions. Its largest new stake was Oneok: 142,999 shares worth $7.46M. The largest sale was Boston Scientific, an estimated $37.8M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 54% a quarter earlier, followed by Energy and Utilities.

  • Bollard Group's largest Q2 2017 buy was Oneok: 142,999 shares worth $7.46M.
  • Bollard Group added most to Alibaba in Q2 2017, an estimated $12.2M increase.
  • Bollard Group's biggest Q2 2017 reduction was Boston Scientific, cutting an estimated $37.8M.
  • Bollard Group fully exited Oneok Partners LP in Q2 2017, selling an estimated $7.71M.
  • Bollard Group's ten largest holdings make up 64% of its $1.85B portfolio in Q2 2017.
  • Bollard Group opened 10 new positions and closed 11 in Q2 2017.
  • Bollard Group's portfolio value rose 6.2% quarter-over-quarter to $1.85B.

Based on Bollard Group's 13F filing for Q2 2017, filed 20 Jul 2017.